Company intelligence / Profile preview

DÁVI Farmacêutica

Ownership: Private
Development stage: Other

Overview

DÁVI is a Portuguese pharmaceutical company with over 100 years of history, specializing in the distribution and promotion of branded ophthalmology and dermatology products. It is recognized as a key player in the Portuguese market for eye health. The company has recently entered into licensing agreements to expand its product offerings.

Therapeutic areas: DermatologyOphthalmology
Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

7 assets

Alergiftalmina

Unknown

6 more assets in the full pipeline.

Request access →

Partnerships

Formosa Pharmaceuticals (licensing agreement for clobetasol propionate ophthalmic suspension)

Beyond the preview

Go deeper on DÁVI Farmacêutica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DÁVI Farmacêutica.

Explore the full profile